Issue link: http://www.e-digitaleditions.com/i/880535
28 OctOber 2017 Inhalation Automated inhaler testing equipment Astech Projects specializes in the supply of automated inhaler test- ing equipment for all device types including DPI, MDI and BAI. Astech's award-winning X-Prod- u c t s ® r a n g e , w h i c h i n c l u d e s Xelair ® , Xelize ® and Xelox ® , pro- vides robust, durable and consist- ent testing for Dose Content Uni- formity (DCU) and Particle Size Determination (PSD) including Andersen and NGI Impactors. Custom automation solutions are also available for waste firing, physical device testing, emitted dose weight, vision and inspec- tion. Astech offers a comprehen- sive maintenance and support ser- vice called REACTS ® , providing peace of mind for the lifetime of the system. Astech Projects Ltd UK: +44 1928 571797 www.astechprojects.com Next Generation Impactor (NGI) MSP Corporation introduced the Model 170 Next Generation Impactor (NGI) in 2001 to improve the accuracy and convenience of particle size dis- tribution testing of inhalable drug products. Over a decade later, with more than 1,000 units in use worldwide, the NGI is now the industry global stan- dard. With a factory in-use-margin of no less than 50% on all of its all-316 stainless steel nozzle pieces, complete flow resistance characterization, con- trolled cup surface roughness and o-ring-free connections, there is only one NGI. MSP remains committed to manufacturing the NGI with utmost fidelity to its original design and solely to the highest standards of quality, including ISO 9001:2008. MSP Corporation US: +1 651 287-8100 www.mspcorp.com Essential studies for product development Proveris by Design TM Lab Studies can help bring a better product to market more quickly by bridging the gap between patient usage, formulation and device performance, through a number of essential studies including patient usage ergonometric study, reference product characterization, device com- ponent optimization, method development, and method verification and transfer. Proveris can also optimize device component selection by assessing how variables in device design and formulation candidates affect spray per- formance, using spray pattern and plume geometry as sensitive analytical techniques. ey can also determine an appropriate device/formulation combination to achieve desired product delivery. Proveris Scientific Corporation US: +1 508 460-8822 www.proveris.com